Miniaturizing VEGF: Peptides mimicking the discontinuous VEGF receptor-binding site modulate the angiogenic response

Sci Rep. 2016 Aug 8:6:31295. doi: 10.1038/srep31295.

Abstract

The angiogenic properties of VEGF are mediated through the binding of VEGF to its receptor VEGFR2. The VEGF/VEGFR interface is constituted by a discontinuous binding region distributed on both VEGF monomers. We attempted to reproduce this discontinuous binding site by covalently linking into a single molecular entity two VEGF segments involved in receptor recognition. We designed and synthesized by chemical ligation a set of peptides differing in length and flexibility of the molecular linker joining the two VEGF segments. The biological activity of the peptides was characterized in vitro and in vivo showing a VEGF-like activity. The most biologically active mini-VEGF was further analyzed by NMR to determine the atomic details of its interaction with the receptor.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Binding Sites
  • Cell Movement
  • Cell Proliferation
  • Circular Dichroism
  • Crystallography, X-Ray
  • Human Umbilical Vein Endothelial Cells
  • Humans
  • Magnetic Resonance Spectroscopy
  • Mice
  • Mice, Inbred C57BL
  • Neovascularization, Pathologic
  • Peptides / chemistry
  • Phosphorylation
  • Protein Binding
  • Protein Structure, Secondary
  • Signal Transduction
  • Vascular Endothelial Growth Factor A / metabolism*
  • Vascular Endothelial Growth Factor Receptor-2 / metabolism*

Substances

  • Peptides
  • Vascular Endothelial Growth Factor A
  • KDR protein, human
  • Kdr protein, mouse
  • Vascular Endothelial Growth Factor Receptor-2